(San Antonio) Privately held San Antonio company, Rapamycin Holdings, has secured exclusive rights to market a formula designed by the Health Science Center and Southwest Research Institute to break down in the intestines instead of the stomach so patients can better absorb it.
A second version of the university's formula, dubbed eRapaNP2g, has significant implications for veterinary care, showing promise in treating feline chronic gingivostomatitis, a painful oral condition in domestic cats.
Houston—The challenge of healthcare innovation is that it’s about more than making technology work.
The bottom line is that any advance in health IT or medical devices must be considered with one thing in mind, said Todd Dunn, director of innovation at Intermountain Healthcare in Salt Lake City, UT: The innovation is going to be used by healthcare providers on patients. “That’s the foundation,” he said. “You must start with empathy for the customer.”
San Antonio — Cardiovate, an early stage San Antonio startup that aims to repair or replace clogged arteries with regenerated tissue has closed a small financing round from angel investors, The University of Texas Horizon Fund, and Targeted Technology, according to its CEO.
Echolase, a young startup with a product that crosses over between technology and life sciences, is on the brink of getting its first outside funding from a local investment group.
(Xconomy Texas, October 4, 2016) The $7.8 million will fund work on the project over three years and includes BioBridge collaborating with three other organizations: the U.S. Army Institute of Surgical Research and two companies that work in stem cell manufacturing, San Antonio-based StemBioSys and Frederick, MD-based RoosterBio. The money was awarded by Medical Technology Enterprise Consortium, a nonprofit created by the U.S. Army’s Medical Research and Materiel Command to fund medical research.
(San Antonio Business Journal) Among physicians who have partnered with medical device and pharmaceutical companies to parlay their intellectual property and subspecialty expertise resulting in improved patient care and outcomes are UT Medicine faculty, Charles Rockwood, M.D. (orthopaedics), Michael Wirth, M.D. (orthopaedics), Ralph DeFronzo, M.D.(internal medicine), and Robert Chilton, D.O. (cardiology).